Exhibit 10.10


June 5, 2021


 


Joseph J. Ferra, Jr.


[*****]


[*****]


[*****]


 


Re: Executive Employment Agreement


 


Dear Joe:


 


On behalf of Elevation Oncology, Inc.
(the “Company”), I am pleased to offer you employment with the Company. The purpose of this letter agreement (the “Agreement”)
is to set forth the terms of your employment with the Company, should you accept our offer.


 


1.            You
will be employed to serve as the Company’s Chief Financial Officer, effective as of June 16, 2021 (the “Effective
Date”). You will be a full-time employee of the Company, and you will report to the Chief Executive Officer (the
 “CEO”) and have such duties and responsibilities as are customary for such position. You agree to devote your full
business time, best efforts, skill, knowledge, attention and energies to the advancement of the Company’s business and
interests and to the performance of your duties and responsibilities as an employee of the Company; provided, however, that you may
provide transitional services to your prior employer up to and including July 23, 2021, to the extent reasonably agreed between
you and the CEO of the Company. You agree to abide by the rules, regulations, personnel practices and policies of the Company and
any changes therein that may be adopted from time to time by the Company. Initially, you will work on a remote basis. Should the
Company establish a principal place of business operations, you will be expected to spend time at such location on terms and
conditions as may be agreed between you and the Company.


 


2.            Your
base salary will be at the rate of $31,666.67 monthly (equivalent to an annualized base salary of $380,000), subject to tax and other
withholdings as required by law, and will be paid on the regularly scheduled payroll dates of the Company. The Board may elect to increase
your base salary periodically based on your performance and/or industry standards for similarly situated executives.


 


3.            Following
the end of each fiscal year and subject to the approval of the Company’s Board (or a committee thereof), you will be eligible for
a retention and performance bonus, targeted at 40% ($152,000) for a full year, or a prorated portion based upon your date of hire for
the corresponding bonus period) of your annualized base salary as determined by the Board (or a committee thereof) in good faith based
on your individual performance and the Company’s performance during the applicable fiscal year, including, without limitation, based
on the completion of or progress towards the deliverables listed in Attachment A as it relates to 2021. If a bonus is awarded,
unless otherwise specifically provided by the Board or committee administering such plan, it shall be paid on or before January 31st
of the year following the year in which such bonus was earned. You must be an active employee of the Company on the date any bonus is
distributed in order to be eligible for and to earn a bonus award, as it also serves as an incentive to remain employed by the Company.
The Board may elect to increase your retention and performance bonus target based on your performance and/or industry standards for similarly
situated executives.


 



     


     


    




 


4.            You
will also receive a one-time signing bonus in the amount of $75,000 which will be payable at the time you receive your first regular pay-check
from the Company following your commencement of employment, subject to tax and other withholdings as required by law. This entire amount
of the signing bonus will be repayable by you to the Company in the event you voluntarily terminate your employment or are terminated
for Cause (as defined below) prior to the completion of one (1) year of service with the Company. Two-thirds of the signing bonus
($50,000) will be repayable by you to the Company in the event you voluntarily terminate your employment or are terminated for Cause (as
defined below) following the completion of one (1) year of service with the Company but prior to the completion of two (2) years
of service with the Company. One-third of the signing bonus ($25,000) will be repayable by you to the Company in the event you voluntarily
terminate your employment or are terminated for Cause (as defined below) following the completion of two (2) years of service with
the Company but prior to the completion of three (3) years of service with the Company.


 


5.            You
may participate in any and all benefit programs that the Company establishes and makes available to its employees from time to time, provided
you are eligible under (and subject to all provisions of) the plan documents governing those programs. The benefit programs made available
by the Company, and the rules, terms and conditions for participation in such benefit programs, may be changed by the Company at any time
without advance notice (other than as required by such programs or under law). For so long as you remain employed with the Company, but
only until and unless the Company adopts a group health plan that applies to all Company employees, the Company will bear the cost of
health insurance for you and your immediate family which may, at the discretion of the Company, be effected by reimbursing you for paid
COBRA premiums for continuation coverage with your former employer, provided, however, that such amount shall be subject to applicable
taxes and withholdings (which will be satisfied from your other base wages). You will also be entitled to indemnification by the Company
with respect to your service as an officer of the Company pursuant to an Indemnification Agreement substantially similar to the NVCA form
agreement.


 


6.            You
are eligible for five (5) weeks of vacation per calendar year to be taken at such times as will not materially interfere with the
performance of your duties. The number of vacation days for which you are eligible shall accrue at the rate of 2.08 days per month that
you are employed during such calendar year. Up to three (3) vacation days earned in one calendar year may be carried forward and
used in the subsequent calendar year.


 


7.            Subject
to the approval of the Board, within sixty days of the Effective Date, the Company will grant to you a stock option (the “Initial
Option Grant”) under the Company’s 2019 Stock Incentive Plan (the “Stock Plan”) to purchase 1,005,612 shares
of common stock of the Company, at an exercise price equal to the fair market value of the common stock on the date of grant, as determined
by the Board (the “Fair Market Value Price”).  The Initial Option Grant will be evidenced in writing by, and subject
to, the terms of the Stock Plan and a stock option agreement provided by the Company, which agreement will specify that (a) the
options subject to the Initial Option Grant will vest, subject to your continued service, (x) as to 25% of the underlying shares
on the first anniversary of your start date, and (y) as to the balance in equal 1/36th monthly installments thereafter
until the fourth anniversary of your start date; and (b) the options subject to the Initial Option Grant shall vest, subject to
your continued service, as to 100% of the underlying shares if, within 12 months following a Change of Control, (i) your employment
with the Company or its acquirer or successor is terminated without Cause (as defined below), or (ii) you resign from employment
with the Company or its acquirer or successor with Good Reason (as defined below), and in either case, you make effective a general release
of claims in favor of the Company in a form prescribed by, and in a deadline set by, the Company at the time of your termination.


 






    - 2 -


     


    

 


8.            Further,
subject to the approval of the Board, within sixty days of the Effective Date, the Company will grant to you restricted stock units (“RSUs;”
this grant, the “RSU Grant”) under the Stock Plan covering a number of shares determined pursuant to the following formula:


 


((1,005,612 * the Fair Market Value Price) –
(1,005,612 * $0.73) ) /

the Fair Market Value Price = Number of RSUs


 


The RSU Grant will be evidenced in writing by,
and subject to, the terms of the Stock Plan and a restricted stock unit agreement provided by the Company, which agreement will specify
that (a) the RSUs subject to the RSU Grant will vest, subject to your continued service, (x) as to 25% of the underlying shares
on the first anniversary of your start date, and (y) as to the balance in equal 1/12th quarterly installments thereafter
until the fourth anniversary of your start date; and (b) the RSUs subject to the RSU Grant shall vest, subject to your continued
service, as to 100% of the underlying shares if, within 12 months following a Change of Control, (i) your employment with the Company
or its acquirer or successor is terminated without Cause (as defined below), or (ii) you resign from employment with the Company
or its acquirer or successor with Good Reason (as defined below), and in either case, you make effective a general release of claims in
favor of the Company in a form prescribed by, and in a deadline set by, the Company at the time of your termination.


 


9.            In
addition, the Board may, in its discretion, elect to grant you additional stock options based on your performance, a material increase
in the number of fully diluted shares of the Company’s common stock and/or industry standards for similarly situated executives.


 


10.          For
purposes of this Agreement:


 


“Cause”
means any of: (a)  your conviction of, or plea of guilty or nolo contendere to, any crime involving dishonesty or moral turpitude
or any felony; or (b) a finding by the Board in its sole discretion that you have (i) engaged in dishonesty, willful misconduct
or gross negligence that materially injures or would reasonably be expected to materially injure the reputation, business or business
relationships of the Company, (ii) committed an act or inaction, which, in either case, materially injures the reputation, business
or business relationships of the Company, (iii) materially breached the terms of any invention and non-disclosure agreement or non-competition
and non-solicitation agreement with the Company which breach is not cured within ten days written notice thereof; or (iv) failed
or refused to comply in any material respect with the Company’s material policies or procedures and in a manner that materially
injures or would reasonably be expected to materially injure the reputation, business or business relationships of the Company, or (v) materially
or continuously failed to perform in a manner satisfactory to the Board and consistent with your position, provided that, in the case
of (iv) and (v), you were given written notice of such violation or failure by the Board and a period of 30 days to cure (provided
that the Board determines that such violation or failure is curable).


 






    - 3 -


     


    

 


“Change of
Control” shall mean, regardless of form thereof, consummation of (a) the sale of all or substantially all of the assets of
the Company (on a consolidated basis) to an unrelated person or entity, (b) a merger, reorganization or consolidation in which the
outstanding shares of capital stock of the Company are converted into or exchanged for securities of the successor entity and the holders
of the Company’s outstanding voting power immediately prior to such transaction do not own a majority of the outstanding voting
power of the successor entity immediately upon completion of such transaction, (c) the sale of all or a majority of the outstanding
capital stock of the Company to an unrelated person or entity or (d) any other transaction in which the owners of the Company’s
outstanding voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the successor
entity immediately upon completion of the transaction; provided, however, that “Change of Control” shall not include any financing
transaction of the Company (whether public or private) that would otherwise be and/or trigger a “Change of Control” under
(c) and/or (d) above.


 


“Good Reason”
shall mean (i) any action by the Company which results in a material diminution in your position, authority, duties or responsibilities,
(ii) a material reduction in the aggregate of your base compensation, other than a reduction in monthly base salary of no more than
twenty percent (20%) as a result of across-the-board reductions or terminations affecting employees of the Company generally, or (iii) the
Company’s material breach of Paragraph 3 of this Agreement; provided, however, that the conditions described immediately above in
clauses (i) through (iii) shall not give rise to a termination for Good Reason unless you have notified the Company in writing
within thirty (30) days of the first occurrence of the facts and circumstances claimed to provide a basis for the termination for Good
Reason, the Company has failed to correct the condition within thirty (30) days after the Company’s receipt of such written notice,
and you actually terminate employment with the Company within sixty (60) days of the first occurrence of the condition.


 


11.          You
will be required to execute a Proprietary Information, Inventions, Non-Competition and Non-Solicitation Agreement in the form attached
as Attachment B (“Proprietary Information Agreement”) as a condition of employment.


 


12.          You
represent that you are not bound by any employment contract, restrictive covenant or other restriction preventing (or that purports to
prevent) you from entering into employment with or carrying out your responsibilities for the Company, or which is in any way inconsistent
with the terms of this letter.


 


13.          You
agree to provide to the Company, within three days of your hire date, documentation of your eligibility to work in the United States,
as required by the Immigration Reform and Control Act of 1986. You acknowledge and agree that your employment is subject to and conditioned
upon your eligibility to work in the United States.


 






    - 4 -


     


    

 


14.          This
letter shall not be construed as an agreement, either expressed or implied, to employ you for any stated term, and shall in no way alter
the Company’s policy of employment at will, under which both you and the Company remain free to terminate the employment relationship,
with or without cause, at any time, with or without notice. Although your job duties, title, compensation and benefits, as well as the
Company's personnel policies and procedures, may change from time to time, the "at-will" nature of your employment may only
be changed by a written agreement signed by you and the CEO, which expressly states the intention to modify the at-will nature
of your employment. Similarly, nothing in this letter other than Paragraph 7 shall be construed as an agreement, either express or implied,
to pay you any compensation or grant you any benefit beyond the end of your employment with the Company.


 


15.          The
Company’s offer of at-will employment is contingent upon your authorization and successful completion of background and reference
checks. You will be required to execute authorizations for the Company to obtain consumer reports and/or investigative consumer reports
and use them in conducting background checks as a condition to your employment. The Company may obtain background reports both pre-employment
and from time to time during your employment with the Company, as necessary.


 


16.          The
Company's premises, including all workspaces, furniture, documents, and other tangible materials, and all information technology resources
of the Company (including computers, data and other electronic files, and all internet and email, whether on Company premises or remote)
are subject to oversight and inspection by the Company at any time. Company employees should have no expectation of privacy with regard
to any Company premises, materials, resources, or information.


 


17.          This
offer letter is your formal offer of employment and supersedes any and all prior or contemporaneous agreements, discussions and understandings,
whether written or oral, relating to the subject matter of this letter or your employment with the Company. The resolution of any disputes
under this letter will be governed by the laws of the State of Delaware.


 


* * *


 


If you agree with the provisions
of this letter, please sign the enclosed duplicate of this letter in the space provided below and return it to me, by June 7, 2021.
If you do not accept this offer by this date, this offer will be revoked.


 


	 	 	Very Truly Yours,
	 	 	 
	 	 	By:	 /s/ Shawn M. Leland
	 	 	Name:	Shawn M. Leland, PharmD, RPh
	 	 	Title:	Founder and CEO




 






    - 5 -


     


    

 


The foregoing correctly sets forth the terms
of my employment by Elevation Oncology, Inc. I am not relying on any representations pertaining to my employment other than those
set forth above. I have read, understand, and agree to all of the above and hereby accept the Company’s offer of employment on
the above terms and conditions. I understand that my employment with the Company is considered “at will” meaning that either
the Company or I may terminate this employment relationship at any time for any reason without cause or notice. I further understand
and agree that my employment is contingent upon my execution of the Proprietary Information Agreement.


 


	 /s/ Joseph J. Ferra, Jr.	 	Date:	6/6/21







Name: Joseph J. Ferra, Jr.


 






    - 6 -


     


    

 


Attachment A


 


Bonus Criteria for 2021 





 




    


     


    

 


Attachment B


 


Proprietary Information Agreement


 




    


     


    

 


Joseph J. Ferra, Jr.


 


Proprietary
Information, Inventions,


Non-Competition
and Non-solicitation Agreement


 


This Proprietary Information, Inventions,
Non-Competition and Non-Solicitation Agreement (“Agreement”) is made in consideration for my employment by Elevation
Oncology, Inc., a Delaware corporation (the “Company”), and compensation now and hereafter paid to me. I understand
and agree as follows:


 


1.            Nondisclosure
And Use. All Proprietary Information (as defined below) is and shall remain the sole and exclusive property of the Company.
At all times during my employment and afterwards I will not disclose or use any Proprietary Information, except as required in connection
with my work for the Company. I will take reasonable precautions to safeguard the Proprietary Information. I understand that I am also
prohibited from accessing the Company’s computer systems and databases for any unauthorized, improper or competitive purpose, both
while employed and thereafter. The term “Proprietary Information” means any information that relates to the Company’s
actual or anticipated business or research and development, technical data, trade secrets or know-how, including, but not limited to,
research, product plans or other information regarding the Company’s products or services and markets therefor, customer lists and
customers, software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware configuration
information, marketing, finance, other business information or other non-public information that a competitor of the Company could use
to the competitive disadvantage of the Company. I further understand that Proprietary Information (i) includes the foregoing information
even if disclosed to me in connection with the contemplation of my becoming an employee of the Company, i.e., prior to the effective date,
(ii) does not include any of the foregoing items that is or becomes publicly known through no wrongful act or omission of mine or
of others who were under confidentiality obligations as to the item or items involved. I further understand that, in accordance with the
Defend Trade Secrets Act of 2016, I will not be held criminally or civilly liable under any federal or state trade secret law for
the disclosure of a Company trade secret that is made in confidence to a federal, state, or local government official, either directly
or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law, or is made in a complaint
or other document that is filed under seal in a lawsuit or other proceeding. I further understand that if I file a lawsuit for retaliation
for reporting a suspected violation of law, I may disclose the Company’s trade secrets to my attorney and use the trade secret
information in the court proceeding if any document containing the trade secret is filed under seal and I do not disclose the trade secret,
except pursuant to court order.


 


I will not disclose or use any information received
by the Company from third parties, except as required in connection with my work for the Company. I will not improperly use or disclose
any confidential information or trade secrets of any third party or former employer to whom I have an obligation of confidentiality. My
performance of all the terms of this Agreement and as an employee of the Company does not breach any agreement by which I am legally bound,
and I agree not to become a party to any such agreement.


 


2.            Assignment
of Inventions. I agree to assign and hereby assign to the Company upon creation all my right, title and interest in and to
any and all inventions, trade secrets, confidential and proprietary information, and work-product I conceive, create or develop, whether
or not eligible for or covered by patent, copyright or trade secret protection (collectively, “Inventions”) and whether
or not such Inventions constitute works for hire or would otherwise belong to the Company by operation of law, which (i) are related
to the Company’s actual or demonstrably anticipated business or research and development or (ii) were developed during Company
time or using Company resources, that become known to, or are made, conceived, reduced to practice or learned by me, either alone or jointly
with others, during the period of my employment with the Company (“Company Inventions”). All original works of authorship
which are made by me (solely or jointly with others) within the scope of my employment and which are protectable by copyright are “works
made for hire” pursuant to United States Copyright Act (17 U.S.C. §101). I further waive any moral rights, if any, I may
have in any copyrightable subject matter of any Company Inventions. I will keep an adequate and current record of all Proprietary Information
and Company Inventions, which records shall be the property of the Company.


 






     1 of 14


     


    

 


I will not incorporate any non-assignable inventions
(defined below) or Prior Inventions (defined below) into any work I perform for the Company without the Company’s prior written
consent, and, if I do, the Company is hereby granted a nonexclusive, royalty-free, irrevocable, perpetual, fully-paid, worldwide license
(with rights to sublicense) in and to all present and future rights in the same. I will promptly disclose to the Company all inventions
I develop by myself or jointly with others which I believe are “non-assignable inventions” under applicable law. For clarity,
work or inventions I made prior to the commencement of my employment with the Company which are owned in whole or in part by me are described
on the signature page hereto; or, if left blank, I affirm there are no such “Prior Inventions.”


 


During my employment and thereafter, I will
assist the Company in every proper way to obtain and enforce its intellectual property rights, it being understood that the Company shall
compensate me at a reasonable rate after my termination for the time actually spent by me and for any reasonable expenses actually incurred
by me at the Company’s request. If the Company is unable for any reason to secure my signature in connection with obtaining or enforcing
the Company’s intellectual property rights, then I hereby irrevocably appoint the Company and its duly authorized officers and agents
as my agent and attorney in fact, to act on my behalf and to execute and file any required documents and to do all other lawfully permitted
acts in furtherance thereof as if done by me.


 


3.            No
Conflicts or Solicitation. Due to the nature of my position with the Company, I will have access to and learn the Company’s
Proprietary Information which is commercially valuable and of great importance to the Company. To protect the Company’s Proprietary
Information, during my employment, I will not engage in any other employment or other activity that is related to the business in
which the Company is now involved or becomes involved or has plans to become involved, nor will I engage in any other activities that
conflict with my obligations to the Company.


 


In addition, during my employment and for a period
of one year following the termination of my employment with the Company for any reason, I will not, either directly or indirectly,
solicit, induce, or encourage (or attempt to do so) any of the Company’s employees or other service providers to leave their employment/engagement,
or hire or take away such employees or other service providers, either for myself or for any other person or entity. This restriction
includes all those who were employed by or performed services for the Company at any time during the one year period immediately before
the date my employment terminated.


 


In addition, during my employment and for a period
of one year immediately following the termination of my employment with the Company for any reason, I will not, either directly or
indirectly: (a) interfere with the Company’s relationships with any of its customers, prospective customers, suppliers, contractors,
distribution partners, prospective distribution partners, resellers, or any third party regularly dealing with the Company; or (b) solicit,
call upon, divert or actively take away, or attempt to solicit, call upon, divert or take away, for purposes of conducting a business
substantially similar to or competitive with the Company’s business, any of the Company’s customers, prospective customers,
suppliers, contractors, distribution partners, prospective distribution partners, or other third party regularly dealing with the Company.
This restriction includes any customer to which the Company sold any product, or for which the Company performed any service at any time
during the one year period immediately before the date my employment terminated, except that the restriction pertaining to the Company’s
prospective customers only applies if I became familiar with the prospective customer through my employment.


 






     2 of 14


     


    

 


4.            Covenant
Not to Compete. To protect the Company’s Proprietary Information, I agree that during my employment with the Company
and for a period of time equal to six months following the termination of my employment with the Company for any reason, I will not
compete with the Company in the Territory (defined below), which for clarity means that I will not, either directly or indirectly, in
the Territory (i) serve as a consultant, director, manager, employee, officer, partner, or proprietor, for any Restricted Business
(defined below); (ii) have any ownership interest in any Restricted Business other than a passive ownership interest of two percent
or less in an entity whose securities are publicly traded; or (iii) participate in the organization, financing, operation, management
or control of any Restricted Business. “Restricted Business” means business in competition with the Company’s
business as conducted by the Company at any time during the course of my employment with the Company, together with any other business
with which I am actively involved in assisting the Company with researching, developing or marketing at the time of the termination of
my employment. For clarity, the Company’s business as of the date I signed this Agreement includes research and development of monoclonal
antibodies directed to the inhibition of HER3 (human epidermal growth factor receptor 3). For further clarity, this covenant does not
prohibit my employment with competitors of the Company, if the area in which I will be employed/engaged is different from the area of
my employment/engagement with the Company and will not require or inevitably lead to the disclosure of the Company’s Proprietary
Information. “Territory” means: (i) the entire world; (ii) North America; (iii) the United States
of America; (iv) each state in which the Company does business or did business at any time within one year prior to the termination
of my employment with the Company; (v) the States of New York, Massachusetts, Pennsylvania, Connecticut, and New Jersey; (vi) the
State of New York; and (vii) New York County. The foregoing Territory is reasonable and reasonably necessary to protect the Proprietary
Information. If, however, a court determines that the Territory described above in subparagraph (i) is too restrictive, then the
parties agree the Territory shall be reduced to the area specified in each of the following subsections and in the following order until
the court determines an acceptable geographic area: subparagraphs (ii), (iii), (iv), (v), (vi) or (vii). If the court determines
that all of the areas are too restrictive, then the parties agree that the court may reduce or limit the area to enable the intent of
this Section to be enforced in the largest acceptable area.


 


5.            Reasonable.
The nature of the Company’s products and services are such that its natural market is worldwide. The restrictions in
Sections 3 and 4 are reasonable and are reasonably necessary for the protection of Proprietary Information and provide a reasonable way
of protecting the Company’s business value which will be imparted to me. Through my employment I will receive adequate consideration
for any loss of opportunity associated with their provisions. The length of time, geographic area and any other restrictions contained
in this Agreement are reasonable to protect the legitimate interests of the Company and do not unfairly restrict or penalize me. However,
if any restriction set forth in Section 3 is found by a court to be unenforceable because it extends for too long a period of time
or over too great a range of activities or in too broad a geographic area, it shall extend only over the maximum period of time, range
of activities or geographic area as to which such court shall determine it to be enforceable. A breach of any provision(s) of this
Agreement tolls the running of the limitation period and the restriction period with respect to such provision(s) during the breach.


 


6.            Non-Disparagement.
At all times during my employment and afterwards I will not, directly or indirectly, disparage the Company, its officers or directors,
its business, services, products or personnel. This provision is not intended to restrict communications or actions legally protected
by state or federal law, including the National Labor Relations Act.


 


7.            Use
of Likeness. I will not, directly or indirectly, endorse, speak on behalf of, or allow my name or likeness to be used to in
any way promote any competitive business or competing product during my employment with the Company. During my employment and after my
employment with the Company ends, I consent to the Company’s use of my image, likeness, voice, and other characteristics in
connection with the Company’s operation of the Company’s business and its promotion and sale of its products and services.
I release the Company from any cause of action which I may have or may have arising out of the use, distribution, adaptation, reproduction,
broadcast, or exhibition of such characteristics.


 






     3 of 14


     


    

 


8.            Social
Media. The Company owns all Company-related digital and social media accounts (including all passwords, data posts, digital
works and goodwill therein) that I may create, manage, contribute to, or administer during my employment with the Company and including
all “followers,” connections, fans, subscribers, contacts and other relationships created under such accounts. My use of such
accounts will be in accordance with all Company policies in effect from time to time. At any time upon request and immediately upon my
termination of employment for any reason, I will surrender full control and access to such accounts to the Company.


 


9.            Legal
And Equitable Remedies. Because my services are personal and unique and the Company may not have an adequate remedy at law
for a breach or threatened breach of this Agreement, the Company may, in addition to other remedies at law or in equity which may be available,
enforce this Agreement by injunction, specific performance or other equitable relief, all without bond.


 


10.          Employment
At-Will and Other Matters. My employment is at-will, meaning that I or the Company can end my employment at any time for any
reason. The Company may notify any employer I may have in the future of my rights and obligations under this Agreement. At any time upon
request and on termination of my employment, I will return all Company property to the Company immediately. In addition, all Company
property and property situated on the Company’s premises is subject to inspection by the Company at any time and I understand that
I have no expectation of privacy with regard to the same, including without limitation work areas, computer and communications systems,
email and internet records handheld devices or other property used to conduct the business of the Company. Nothing in this Agreement is
intended to limit my rights to discuss the terms, wages, and working conditions of employment, as protected by applicable law.


 


11.          General
Provisions. Delaware law governs this Agreement. I consent to the personal jurisdiction of and venue in the state and federal
courts located in Delaware. If any provision of this Agreement is found invalid or unenforceable, no other provision is affected. This
Agreement is binding on my heirs and all legal representatives. This Agreement benefits and may be enforced by the Company and its agents,
parents, subsidiaries, affiliates, successors and assigns. The provisions of this Agreement survive the termination of my employment
and the assignment of this Agreement by the Company to any assignee or successor. A waiver by the Company of any breach is not a waiver
of any prior or subsequent breach, and a waiver of any specific right shall not be construed as a waiver of any other right. For purposes
of this Agreement, the term “employee” shall be deemed to include “consultant,” “independent contractor”
or “director,” and the term “employment,” or any variation thereof, shall be deemed to include “engagement”
or any variation thereof. My obligations under this Agreement shall apply to any time during which I was previously employed, or am in
the future employed, by the Company if no other agreement governs during such period. Any subsequent change or changes in my duties,
salary or compensation will not affect the validity or scope of this Agreement. This Agreement is effective as of the first day of my
employment with the Company. This Agreement is the final, complete and exclusive agreement between me and the Company with respect to
the subject matter hereof and supersedes all prior discussions or agreements, written or verbal, between us with respect to the subject
matter hereof. Amendments or waivers to this Agreement must be in writing and signed by the party to be charged to be effective.


 






     4 of 14


     


    

 


	I
    HAVE READ THIS AGREEMENT CAREFULLY AND UNDERSTAND ITS TERMS.	 	ACCEPTED
    AND AGREED TO:
	 	 	Elevation Oncology, Inc.
	 	 	 
	Dated:	June 6,
    2021	 	
	 	 	 	 






 


	  /s/
    Joseph J. Ferra, Jr.	 	By:	/s/
    Shawn M. Leland
	Signature/Printed
    Name	 	 	Signature/Printed
    Name
	 	 	 	
	[*****]	 	 
	[*****]	 	Title:	Founder
    and CEO
	Address	 	 



 






     5 of 14


     


    

 


******************************************************************************





“Prior
Inventions”





******************************************************************************


 


If you have Prior Inventions, please list them
in the space below. If no Prior Inventions are identified below, you are affirming that you have no Prior Inventions to identify. If you
need extra pages, please attach them and indicate below.


 


	Title	 	Date of Prior Invention	 	Brief Description




 


If a prior confidentiality agreement prevents disclosure
above, instead provide a cursory name for each prior invention, a listing of the party or parties to whom it belongs and description of
the relationship to that party.


 


	Invention	 	Parties	 	Relationship




 


******************************************************************************


 






     1 of 14